Journal
JOURNAL OF CLINICAL PSYCHIATRY
Volume 72, Issue 2, Pages 183-193Publisher
PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.09m05311yel
Keywords
-
Categories
Funding
- National Alliance for Research on Schizophrenia and Depression (NARSAD)
- NIH [MH-04844, MH-10948]
- Atlas Foundation
- Bruce J. Anderson Foundation
- McLean Private Donors Research Fund
- Spanish Ministry of Education and Science and CIBERSAM
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Forrest
- GlaxoSmithKline
- Janssen-Cilag
- Jazz
- Merck
- Novartis
- Organon
- Otsuka
- Pfizer
- Sanofi
- Servier Corporations
- [MH-47370]
- [MH-73049]
Ask authors/readers for more resources
Objective: Because clinical and biologic research and optimal clinical practice require stability of diagnoses over time, we determined stability of ICD-10 psychotic disorder diagnoses and sought predictors of diagnostic instability. Method: Patients from the McLean-Harvard International First-Episode Project, conducted from 1989 to 2003, who were hospitalized for first psychotic illnesses (N=500) were diagnosed by ICD-10 criteria at baseline and 24 months, on the basis of extensive prospective assessments, to evaluate the longitudinal stability of specific categorical diagnoses and predictors of diagnostic change. Results: Diagnostic stability averaged 90.4%, ranking as follows: schizoaffective disorder (100.0%) > mania with psychosis (99.0%) > mixed affective episode (94.9%) > schizophrenia (94.6%) > delusional disorder (88.2%) > severe depressive episode with psychotic symptoms (85.2%)> acute psychosis with/without schizophrenia symptoms = unspecified psychosis (all 66.7%) > > acute schizophrenia-like psychosis (28.6%). Diagnoses changed by 24 months of follow-up to schizoaffective disorder (37.5%), bipolar disorder (25.0%), schizophrenia (16.7%), or unspecified non-organic psychosis (8.3%), mainly through emerging affective features. By logistic regression, diagnostic change was associated with Schneiderian first-rank psychotic symptoms at intake > lack of premorbid substance use. Conclusions: We found some psychotic disorder diagnoses to be more stable by ICD-10 than DSM-IV criteria in the same patients, with implications for revisions of both diagnostic systems. J Clin Psychiatry 2011;72(2): 183-193 (C) Copyright 2010 Physicians Postgraduate Press, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available